Cabot Corporation (NYSE:CBT) Stock Rated "Hold" by Sell-Side Analysts

Key Points

• Analysts maintain a “Hold” consensus on Cabot, with four holds, two buys, and one sell among seven analysts. The average 12-month price target is $89, above the reported share price of $76.29.
• Cabot reported quarterly EPS of $1.67, narrowly beating estimates, while revenue rose 6.4% year over year to $982 million. The company guided to fiscal 2026 EPS of $6.15–$6.45.
• CEO Sean Keohane sold 134,895 shares for approximately $11.5 million, and insiders sold about $19.6 million of stock over the past 90 days. Cabot also pays an annualized dividend of $1.89 per share, yielding roughly 2.5%.

Cabot Corporation (NYSE:CBT - Get Free Report) has earned a consensus rating of "Hold" from the seven analysts that are covering the firm, MarketBeat reports. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have assigned a buy rating to the company. The average twelve-month price target among brokerages that have covered the stock in the last year is $89.00.

CBT has been the topic of several recent analyst reports. Wall Street Zen raised shares of Cabot from a "hold" rating to a "buy" rating in a research note on Sunday, August 9th. JPMorgan Chase & Co. raised their target price on Cabot from $70.00 to $78.00 and gave the stock an "underweight" rating in a research report on Friday, August 7th. Mizuho upped their price target on Cabot from $80.00 to $90.00 and gave the company a "neutral" rating in a research report on Thursday, June 25th. UBS Group dropped their price target on Cabot from $97.00 to $92.00 and set a "neutral" rating on the stock in a research report on Wednesday, August 5th. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Cabot in a research report on Friday, August 21st.

Insider Activity

In related news, CEO Sean Keohane sold 134,895 shares of the firm's stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the completion of the sale, the chief executive officer directly owned 404,134 shares in the company, valued at approximately $34,351,390. This trade represents a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Insiders have sold 229,597 shares of company stock valued at $19,646,746 over the last ninety days. 3.08% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Cabot

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in CBT. Northwestern Mutual Wealth Management Co. purchased a new position in shares of Cabot during the 2nd quarter valued at $33,000. Rothschild Investment LLC raised its holdings in shares of Cabot by 170.4% during the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company's stock worth $27,000 after acquiring an additional 259 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its position in Cabot by 76.8% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 944 shares of the specialty chemicals company's stock valued at $63,000 after purchasing an additional 410 shares during the last quarter. Global Retirement Partners LLC acquired a new stake in Cabot during the second quarter valued at $88,000. Finally, Hantz Financial Services Inc. grew its stake in Cabot by 131.0% in the fourth quarter. Hantz Financial Services Inc. now owns 991 shares of the specialty chemicals company's stock valued at $66,000 after purchasing an additional 562 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company's stock.

Cabot Stock Down 0.8%

Shares of Cabot stock opened at $76.29 on Friday. The stock's fifty day moving average is $83.09 and its 200-day moving average is $82.16. The company has a quick ratio of 0.97, a current ratio of 1.47 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $3.94 billion, a PE ratio of 21.49, a price-to-earnings-growth ratio of 10.10 and a beta of 0.83. Cabot has a 12-month low of $58.33 and a 12-month high of $94.53.

Cabot (NYSE:CBT - Get Free Report) last announced its earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, topping the consensus estimate of $1.66 by $0.01. The company had revenue of $982.00 million during the quarter, compared to analysts' expectations of $943.16 million. Cabot had a net margin of 5.23% and a return on equity of 20.29%. The business's revenue for the quarter was up 6.4% on a year-over-year basis. During the same period last year, the company posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities analysts anticipate that Cabot will post 6.35 earnings per share for the current year.

Cabot Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Friday, August 28th were issued a $0.4725 dividend. The ex-dividend date was Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.5%. Cabot's dividend payout ratio is currently 53.24%.

About Cabot

Cabot Corporation NYSE: CBT is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company develops and manufactures materials used by industrial and consumer-product manufacturers worldwide.

Cabot's products include reinforcing carbon blacks used in tires, automotive components, and other rubber products; specialty carbon blacks used in coatings, plastics, inks, and batteries; and fumed silica used in adhesives, sealants, coatings, and personal-care applications.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.